Literature DB >> 24216625

Saussurea lappa alleviates inflammatory chemokine production in HaCaT cells and house dust mite-induced atopic-like dermatitis in Nc/Nga mice.

Hye-Sun Lim1, Hyekyung Ha2, Mee-Young Lee2, Seong-Eun Jin2, Soo-Jin Jeong2, Woo-Young Jeon1, Na-Ra Shin2, Dai-Eun Sok3, Hyeun-Kyoo Shin4.   

Abstract

Saussurea lappa is a traditional herbal medicine used for to treat various inflammatory diseases. In this study, we investigated the protective effects of S. lappa against atopic dermatitis using human keratinocyte HaCaT cells, murine mast cell line MC/9 cells, and a house dust mite-induced atopic dermatitis model of Nc/Nga mice. Treatment with the S. lappa caused a significant reduction in the mRNA levels and production of inflammatory chemokines and cytokine, including thymus- and activation-regulated chemokine (TARC), macrophage-derived chemokine (MDC), regulated on activation, normal T-cell expressed and secreted (RANTES), and interleukin-8 (IL-8) in tumor necrosis factor-α/interferone-γ-stimulated HaCaT cells. S. lappa exhibited the significant reduction in histamine production in MC/9 cells. In the atopic dermatitis model, S. lappa significantly reduced the dermatitis score and serum IgE and TARC levels. In addition, the back skin and ears of S. lappa-treated Nc/Nga mice exhibited reduced histological manifestations of atopic skin lesions such as erosion, hyperplasia of the epidermis and dermis, and inflammatory cell infiltration. In conclusion, an extract of S. lappa effectively suppressed the development of atopic dermatitis, which was closely related to the reduction of chemokines and cytokine. Our study suggests that S. lappa may be a potential treatment for atopic dermatitis. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Chemokines; Keratinocyte; Nc/Nga mice; Saussurea lappa

Mesh:

Substances:

Year:  2013        PMID: 24216625     DOI: 10.1016/j.fct.2013.10.050

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Spatholobus suberectus Dunn Water Extract Ameliorates Atopic Dermatitis-Like Symptoms by Suppressing Proinflammatory Chemokine Production In Vivo and In Vitro.

Authors:  Hyun-Kyung Song; Sun Haeng Park; Hye Jin Kim; Seol Jang; Taesoo Kim
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

2.  Management of Atopic Dermatitis Via Oral and Topical Administration of Herbs in Murine Model: A Systematic Review.

Authors:  Vivi Nur Khalieda Mohd Kasim; Siti Mahirah Noble; Kong Yen Liew; Ji Wei Tan; Daud Ahmad Israf; Chau Ling Tham
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

3.  The Genome-Wide Expression Profile of Saussurea lappa Extract on House Dust Mite-Induced Atopic Dermatitis in Nc/Nga Mice.

Authors:  Hye-Sun Lim; Hyekyung Ha; Hyeun-Kyoo Shin; Soo-Jin Jeong
Journal:  Mol Cells       Date:  2015-08-21       Impact factor: 5.034

4.  Ma Huang Tang Suppresses the Production and Expression of Inflammatory Chemokines via Downregulating STAT1 Phosphorylation in HaCaT Keratinocytes.

Authors:  Hye-Sun Lim; Chang-Seob Seo; Seong-Eun Jin; Sae-Rom Yoo; Mee-Young Lee; Hyeun-Kyoo Shin; Soo-Jin Jeong
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-26       Impact factor: 2.629

5.  Therapeutic effects of orally administered CJLP55 for atopic dermatitis via the regulation of immune response.

Authors:  Kyeong Eun Hyung; Soo Jeong Kim; Ye Won Jang; Da Kyoung Lee; Kee Hyeob Hyun; Byoung Seok Moon; Bongjoon Kim; Heeyoon Ahn; So-Young Park; Uy Dong Sohn; Eon Sub Park; Kwang Woo Hwang
Journal:  Korean J Physiol Pharmacol       Date:  2017-04-21       Impact factor: 2.016

Review 6.  Sesquiterpene lactones of Aucklandia lappa: Pharmacology, pharmacokinetics, toxicity, and structure-activity relationship.

Authors:  Xin-Nan Liu; Hui-Min Li; Shu-Ping Wang; Jing-Ze Zhang; Dai-Lin Liu
Journal:  Chin Herb Med       Date:  2021-02-16

7.  Saussureae Radix Attenuates Neuroinflammation in LPS-Stimulated Mouse BV2 Microglia via HO-1/Nrf-2 Induction and Inflammatory Pathway Inhibition.

Authors:  You-Chang Oh; Wei Li; Jang-Gi Choi
Journal:  Mediators Inflamm       Date:  2021-03-18       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.